✦ LIBER ✦

S5-01-04: Insulin and Alzheimer's disease therapeutics

✍ Scribed by Suzanne Craft

Book ID: 118464152
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 54 KB
Volume: 4
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2008.05.561

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S5-04-01: Pharmacological treatments of

S5-04-01: Pharmacological treatments of psychiatric symptoms in Alzheimer’s disease

✍ Pierre N. Tariot 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 54 KB

S5-01-01: Omega-3 fatty acids in Alzheim

S5-01-01: Omega-3 fatty acids in Alzheimer‘s disease

✍ Maria E. Eriksdotter Jönhagen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

S5-01-01 APOE and oxysterols as modulato

S5-01-01 APOE and oxysterols as modulators of Alzheimer's disease pathogenesis

✍ Suzana Petanceska 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Insulin resistance and Alzheimer's disea

Insulin resistance and Alzheimer's disease

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

S2-04-04 Imaging and therapeutic approac

S2-04-04 Imaging and therapeutic approaches for β-sheet structures in prion and Alzheimer's diseases

✍ Thomas Wisniewski; Joanna Pankiewicz; Henrieta Scholtzova; Goni Fernando; Jose A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Cdk5, a therapeutic target for Alzheimer

Cdk5, a therapeutic target for Alzheimer's disease?

✍ Li-Huei Tsai; Ming-Sum Lee; Jonathan Cruz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Alzheimer's disease (AD) represents the leading cause for senile dementia affecting more than 4 million people worldwide. AD patients display a triad of pathological features including brain atrophy caused by neuronal loss, h-amyloid plaque and neurofibrillary tangles. We previously show that Cyclin